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O B J E C T I V E S The purpose of our study was to assess the impact of revised versus original criteria
on the prevalence of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) criteria in
cardiac magnetic resonance (CMR) studies.
B A C KG ROUND Recently, the ARVC/D task force criteria have been revised, aiming for a better
diagnostic sensitivity. The implications of this revision on clinical decision making are unknown.
METHOD S We retrospectively evaluated the CMR scans of 294 patients referred for ARVC/D between
2005 and 2010, and determined the presence or absence of major and minor CMR criteria using the original
and the revised task force criteria. Previously, major and minor abnormalities were identiﬁed by the presence
of right ventricle dilation (global or segmental), right ventricle microaneurysm, or regional hypokinesis. The
revised criteria require the combination of severe regional wall motion abnormalities (akinesis or dyskinesis
or dyssynchrony) with global right ventricle dilation or dysfunction (quantitative assessment).
R E S U L T S Applying the original criteria, 69 patients (23.5%) had major original criteria, versus 19
patients (6.5%) with the revised criteria. Forty-three patients (62.3%) with major original criteria did not
meet any of the revised criteria. Using the original criteria, 172 patients (58.5%) had at least 1 minor
criterion versus 12 patients (4%) with the revised task force criteria; 167 patients (97%) with minor
original criteria did not meet any of the revised criteria. In the subgroup of 134 patients with complete
diagnostic work-up of ARVC, 10 patients met the diagnosis of proven ARVC/D without counting imaging
criteria. Only 4 of 10 met major criteria according to the revised CMR criteria; none met minor criteria.
However, 112 of 124 patients without ARVC/D were correctly classiﬁed as negative by major and minor
criteria (speciﬁcity 94% and 96%, respectively).
CONC L U S I O N S In our experience, the revision of the ARVC/D task force imaging criteria
signiﬁcantly reduced the overall prevalence of major and minor criteria. The revision, although
maintaining a high speciﬁcity, may not have improved the sensitivity for identifying patients with
ARVC/D. Larger studies including follow-up are required. (J Am Coll Cardiol Img 2011;4:282–7) © 2011
by the American College of Cardiology Foundation
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283rrhythmogenic right ventricular cardiomyopa-
thy/dysplasia (ARVC/D) is an inherited car-
diomyopathy characterized by structural
and functional abnormalities due to a
progressive replacement of predominantly right
ventricular myocardium by fibrofatty tissue (1–4).
ARVC/D predisposes patients to complex ventric-
ular arrhythmias and sudden cardiac death, typically
among young subjects.
See page 288
Establishing the clinical diagnosis of ARVC/D
remains challenging because of the lack of a single
test to establish a definite diagnosis. Even endo-
myocardial biopsy, sometimes considered to be the
gold standard for ARVC/D, is limited because the
interventricular septum as a typical sampling site is
less commonly involved (5). In 1994, the Task
Force of the European Society of Cardiology and
the Scientific Council on Cardiomyopathies of the
International Society and Federation of Cardiology
proposed a set of criteria (6). These criteria were
based on medical history, as well as on morpholog-
ical, functional, and structural abnormalities, in-
cluding right ventricular dilation, regional dysfunc-
tion, (fibro)fatty replacement of the right ventricle
(RV), electrocardiographic (ECG) changes, ar-
rhythmias, and a family history of sudden cardiac
death. These original task force criteria (TFC) were
universally used to identify patients with ARVC/D.
They were considered highly specific, but some
authors have suggested that they may lack sensitiv-
ity, especially for early and familial disease (7,8).
Moreover, most of these criteria (global and struc-
tural abnormalities) were based on qualitative rather
than quantitative information and were defined
based on the experience before the wide availability
of cardiac magnetic resonance (CMR).
Over the past 15 years, CMR has emerged as the
noninvasive diagnostic tool of choice for assessing
RV anatomy, structure, and function (9,10). High-
resolution cine imaging with state-of-the-art
steady-state free-precession techniques is widely
considered the gold standard for the assessment of
ventricular volumes, myocardial mass, and systolic
function; and CMR demonstrates high intraob-
server and interobserver agreement and accuracy
(11,12). The high spatial and temporal resolution
enables a detailed assessment of the RV for regions
of severely reduced wall thickness and wall motion
abnormalities.The CMR evidence of intramyocardial fat and
fibrosis in the RV has been used as supportive
diagnostic information; however, because of the
limited specificity of these findings and technical
limitations of CMR in visualizing the thin RV
myocardium, the diagnostic utility of intramyocar-
dial fat and fibrosis as diagnostic targets in
ARVC/D remains controversial (13).
Recently, a revision of the TFC has been pro-
posed, incorporating quantitative assessment of RV
size and RV function (14). On the basis of as yet
unpublished pilot data from a partially genetically
defined cohort of patients, the authors propose
imaging criteria using a combination of RV dilation
and severe regional wall motion abnormalities to
establish evidence for ARVC/D. The main differ-
ences to the previous set of criteria include the
removal of RV microaneurysms (focal akinesis with
early diastolic bulging) (Fig. 1) and segmental RV
dilation, and the use of a different and more detailed
quantitative definition of RV dilation.
The purpose of our study was to assess
the impact of revised versus original crite-
ria on the prevalence of ARVC/D criteria
in CMR studies.
M E T H O D S
Study population. We performed a retro-
spective analysis of patients referred to our
CMR center for ARVC/D between 2005
and 2010. To minimize inappropriate in-
dications, we included only patients re-
Figure 1. Microaneurysm in a Patient With Suspected ARVC
There is a focal outpouching of the free RV wall in early diastole (“e
ing,” arrow). According to the original criteria, this ﬁnding itself wa
criterion while the revised criteria require a combination of regiona
or dyssynchronous contraction with global RV dysfunction or dilatio
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284ferred from cardiologists specialized in electrophys-
iology. All reports included a quantitative
assessment of the RV and, therefore, allowed the
post-hoc application of both sets of criteria.
We examined the CMR studies for the presence
or absence of major and minor criteria for CMR
using both the original TFC and the revised TFC
(Table 1). When analyzing the data using the
revised TFC, RV volumetric criteria and RV func-
tion were assigned strictly quantitatively, using the
quantitative cutoff value from the revised TFC
(Table 1).
CMR protocol. CMR was performed using a 1.5-T
scanner (Magnetom Avanto, Siemens Medical So-
lutions, Erlangen, Germany). The left ventricle
(LV) and RV function were assessed using standard
ECG-gated cine steady-state free-precession se-
quences (typical repetition time [TR]  67, echo
delay time [TE]  1.15, field of view  340 
276). The RV function was assessed in a contiguous
stack of short-axis slices of the RV perpendicular to
the anatomic RV long axis (slice thickness 6-mm,
no gap) to cover the entire RV, and in sagittal
Major and Minor Imaging Criteria According to Original and
riteria
ria Revised Criteria
nd reduced
or
rysms or
l RV
Regional RV akinesia or Regional dyskinesia
or Dyssynchronous RV contraction and
RVEDVI/BSA 110 ml/m2 (male) or
RVEDVI/BSA 100ml/m2 (female) or
RVEF 40%
on and/or
rmal LV) or
kinesia or
V dilation
Regional RV akinesia or Regional dyskinesia
or Dyssynchronous RV contraction and
RVEDVI/BSA 100 to 110 ml/m2
(male) or RVEDVI/BSA 90 to 100 ml/
m2 (female) or RVEF 40% to 45%
ight ventricle; RVEDVI/BSA  right ventricular end-diastolic volume indexed to
right ventricular ejection fraction.
acteristics
Variables Patients (n  294)
43 16
146 (49.6)
VC/D in a ﬁrst-degree relative and/or
ythmia
169 (57.4)
125 (42.6)
57.6 6.1
54.6 7.6
88.2 20.3
c right ventricular cardiomyopathy/dysplasia; LVEF  left ventricular ejectionens as in Table 1.orientation (slice thickness 8-mm, no gap). LV
function was assessed using multiple long-axis
views.
Image analysis. All CMR studies were interpreted
y at least 2 experienced readers (case review dis-
ussions), blinded to the results of other diagnostic
ests. For viewing and for the quantitative analysis
f RV volumes and function, certified CMR image
valuation software was used (cmr42, Circle Cardio-
ascular Imaging, Calgary, Alberta, Canada). The
ndocardial and epicardial LV contours and endo-
ardial RV contours were drawn for each diastolic
nd systolic frame.
Major criteria. Table 1 summarizes the differences
or major and minor criteria between original and
evised TFC. Important to our sample, localized
V microaneurysm and severe segmental RV dila-
ion, originally classified as a major criterion, are not
onsidered a criteria in the revised TFC, but may,
owever, qualify as supportive (RV akinesis).
Minor criteria. Mild segmental RV dilation and
regional RV hypokinesis, originally classified as
minor criteria, are not considered criteria in the
revised TFC.
Statistical analysis. Continuous parameters are ex-
pressed as mean  SD. Criteria were expressed as
dichotomous data. Differences between groups were
assessed by the McNemar test. A p value0.05 was
onsidered significant. Sensitivity and specificity of
MR criteria were calculated for the subgroup of
34 patients with complete information regarding
amily history, ECG changes, tissue characteristics,
nd arrhythmias.
R E S U L T S
During the observed period, 308 patients were
referred. The RV volumes and ejection fraction
(EF) were not assessable for 14 patients owing to
image quality, mostly related to complex arrhythmia
patterns. The study population thus consisted of
294 patients (see Table 2 for patient characteristics).
The most frequent reason for the referral was a
positive family history (ARVC/D and/or sudden
cardiac death) in first-degree relatives and/or doc-
umented arrhythmias.
The prevalence of major and minor criteria ac-
cording to the original and revised TFC is shown in
Figure 2.
Major criteria. Applying the original TFC, 69 pa-
ients (23.5%) had major criteria versus 19 patients
6.5%) with the revised TFC (Fig. 2). The differ-Table 1. Deﬁnition of
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285motion abnormalities or microaneurysms in the
absence of RV dilation, qualifying as a criterion
according to the original but not the revised criteria.
Using the original criteria, localized RV microa-
neurysm was the most frequent major abnormality
(64 of 69 patients), 2 patients showed severe seg-
mental RV dilation, and 3 patients had severe RV
dilation and reduced RVEF. With the revised
TFC, the most frequent major abnormality was the
combination of regional akinesis with moderate to
severe RV dilation or RV dysfunction. One patient
showed regional dyskinesis, and none had dyssyn-
chronous RV contraction.
Of the 69 patients with major criteria according
to the original TFC, only 16 patients (23.1%) had
major criteria according to the revised TFC (p 
0.001). Forty-three patients (62.3%) did not meet
any criteria at all (Fig. 3).
Minor criteria. With the original TFC, 172 patients
58.5%) had minor criteria with the majority of
atients having 1 minor criterion (n  133), 38
atients with 2, and 1 patient with 3 minor criteria.
egional hypokinesia was the most frequent minor
bnormality among patients with 1 minor criterion
n  132). Using the revised TFC left only 12
atients (4%) with minor criteria (Fig. 2). The most
requent minor abnormality was the conjunction of
egional akinesis with mild RV dilation or RV
ysfunction; only 1 patient had regional dyskinesis,
nd none had dyssynchronous RV contraction.
Of the 172 patients initially classified as having
inor criteria, only 2 patients (1.1%) still have
inor criteria using the revised TFC (p  0.001),
nd 167 patients (97%) were reclassified to normal
ccording to the revised TFC (Fig. 4).
Correlation of original and revised criteria for CMR in
clinically proven ARVC/D patients. Detailed informa-
tion about family history, ECG changes, tissue
characteristics, and arrhythmias were obtained for
134 patients. Ten patients met the definite diagno-
sis of proven ARVC without counting imaging
criteria. Applying the original TFC for imaging, 10
patients had abnormalities (9 patients with major
criteria, 1 patient with 1 minor criterion), whereas
using the revised TFC, 4 patients had major crite-
ria, yet 6 patients had no criteria at all. If we add
microaneurysms as a criterion to the modified TF
criteria, the sensitivity increases to 50% (5 of 10
patients).
Correlation of original and revised criteria for CMR in
patients without ARVC/D. One hundred and twenty-
our patients did not meet the criteria for
RVC/D. Applying the old imaging criteria, 4atients were classified as ARVC only because of
he imaging findings. Three of them had at least 1
inor criterion, and 1 patient had a major criterion.
he complete chart of each patient (including
amily history, symptoms, ECG, late potentials,
olter monitoring, and follow-up) has been re-
iewed by a cardiologist specialized in electrophys-
ology. These 4 patients have been considered
ithout ARVC, and they have been included in the
roup of 124 patients without ARVC/D. Using the
evised TFC, the majority of patients had no
riteria (n  112; 90.5%), 7 patients had major
Figure 2. Proportional Incidence of Original and Revised ARVC
The graph shows the different incidence of patients with major crit
minor criteria, or without criteria according to the original cardiac m
resonance criteria (green bars) and the revised criteria (orange bar
Abbreviation as in Figure 1.
Figure 3. Reclassiﬁcation of Patients Initially Classiﬁed as
Having Major Criteria
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classiﬁcation, 16 (23.2%) also had a major criterion according to the
recommendations, 10 patients (14.5%) were reclassiﬁed as having aCriteria
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286criteria (5.5%), and 5 patients had minor criteria
(4%). Specificity of major and minor CMR criteria
for ARVC/D in our sample was higher for the
revised criteria (94% and 96%, respectively) than for
the original criteria (78% and 39%, respectively).
Follow-up. With a mean follow-up of 2.2  1.2
years, 293 patients were still alive; 1 patient died of
cancer. Of 134 patients with complete diagnostic
work-up of ARVC, with a mean follow-up of
2.25 1.25 years, 7 patients underwent insertion of
mplantable cardioverter-defibrillator, all of them
ith proven ARVC. Using the original TFC for
maging, 5 patients had major criteria and 2 had a
inor criterion; applying the revised TFC, 4 pa-
ients had major criteria and 3 had no criteria.
D I S C U S S I O N
To our knowledge, this is the first study to compare
the original and the revised task force imaging
criteria for ARVC/D. In our sample, we observed a
significant decrease in the prevalence of minor and
major CMR criteria for ARVC/D with the revised
TFC, with a potential increase of specificity and
decrease of sensitivity.
In a large cohort of 294 patients referred for
CMR for suspected ARVC/D, only 31 patients
(10.5%) had criteria according to the revised TFC,
compared with 241 patients (82%) according to the
original TFC. Only 37.7% of our patients initially
classified as having major criteria and 2.7% of
patients initially classified as having at least 1 minor
criterion still met imaging criteria for ARVC/D.
The revision of the classification for major and
Reclassiﬁcation of Patients Initially Classiﬁed as
inor Criteria
ients initially classiﬁed as having at least 1 minor criteria, 3
.7%) were reclassiﬁed as having a major criterion, 2 (1.1%) contin-
e a minor criterion, and 167 patients (97%) were reclassiﬁed to
ording to the revised task force criteria.minor structural abnormalities represents a majorchange. Previously, major and minor structural
abnormalities were established with the presence of
RV dilation (visual assessment of global or segmen-
tal dilation), localized microaneurysm, and regional
hypokinesis. Dilation of the RV was initially de-
fined by echocardiography or angiography with no
quantitative limits to differentiate mild from mod-
erate to severe RV dilation. The newly suggested
major and minor criteria are based on data from 108
subjects with newly diagnosed ARVC/D (14). The
CMR data from 44 volunteers were compared with
results obtained from 462 normal subjects. The
combination of regional wall motion abnormalities
(akinesis, dyskinesis, or dyssynchrony) with RV
dilation or RV dysfunction (with quantitative as-
sessment) had a sensitivity of 89% for major criteria
and 78% for minor criteria. In our study, to exclude
the bias due to using different cutoff values to assess
RV dilation and RV dysfunction, we used the same
quantitative cutoff value for both original and re-
vised criteria. However, only 31 patients (10.5%)
had a positive criterion as defined by RV dilation
(19 with moderate to severe RV dilation and 12
with mild RV dilation) in combination with re-
gional or global RV dysfunction. Of 64 patients
with localized microaneurysms according to the
original TFC, only 24 still had a criterion in the
combination with RV dilation or RV dysfunction.
Recently, Cox et al. (15) analyzed 105 patients with
proven ARVC/D (using the 1994 TFC), including
a subgroup of 64 patients with CMR data. Fifteen
of their patients (24%) revealed major or minor
criteria using the new imaging TFC. In a less
strictly defined population (89 family members), 26
subjects had CMR with only 1 patient (3.8%)
showing a structural abnormality using the revised
imaging TFC.
Although our sample size of verified ARVC is
small, our data indicate that the new criteria may
have a limited sensitivity, with only 4 of 10 patients
with a definite diagnosis of ARVC/D having major
criteria. The reason for that may be that the
required combination of regional wall motion cri-
teria with global RV dilation/dysfunction may miss
patients with purely or mainly regional RV abnor-
malities. Therefore, the revision of the criteria may
have missed the goal of increasing the sensitivity of
such criteria, yet have led to an increase of speci-
ficity. If confirmed for a larger population of pa-
tients with verified ARVC, this observation may
have important clinical implications.
A significant limitation of our study is the lack ofFigure 4.
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287ARVC/D and limited follow-up data. However,
the chart of each patient has been reviewed, and the
diagnosis of ARVC/D has been confirmed by
cardiologists specialized in electrophysiology re-
garding the family history, symptoms, ECG abnor-
malities, arrhythmias, tissue characteristics, and
follow-up. Prospective studies will have to be per-
formed using the revised TFC and hard end points
such as appropriate implantable cardioverter-
defibrillator shocks or cardiovascular death.
Our single-site experience may not reflect that of
others. The high incidence of microaneurysms as
major criteria according to the original criteria may
reflect a local tendency to “overcall” this and,
therefore, overestimate the negative impact of the
revision on the sensitivity. We did not utilize late
gadolinium enhancement imaging to assess the
myocardium for areas of fibrous or fibrofatty degen-
eration. Although this was not part of the original
or revised criteria and is challenging in the thin wall
of the RV, the detection of such areas in the LV
may prove useful.
Finally, we have investigated the value of imagingSociety and Federation of Cardiology.
Br Heart J 1994;71:215–8.
1
1
1
ing in arrhythmoge
lar dysplasia: insighthe diagnostic accuracy would also have to be
assessed in the context of combined criteria.
C O N C L U S I O N S
In CMR studies performed for assessing patients
for ARVC/D, the introduction of the revised TFC
for ARVC/D may lead to a decrease of the preva-
lence of major and minor imaging criteria. The
revision may, therefore, not have improved their
sensitivity but, instead, have improved their speci-
ficity for identifying patients with ARVC/D. Pro-
spective studies should be performed to study the
prognostic value of the new imaging criteria.
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